How accurate is <sup>68</sup>Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (<sup>68</sup>Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.
Urologic oncology, cilt.40, sa.1, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 40 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.urolonc.2021.07.006
- Dergi Adı: Urologic oncology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Anahtar Kelimeler: Intermediate-high risk prostate cancer, Radical prostatectomy, Lymph node staging, (68)Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-68-PSMA PET/CT), PSMA, DISSECTION, EXPRESSION, DIAGNOSIS, CT
- İstanbul Üniversitesi Adresli: Evet
Özet
Background and aim: Gallium-68 (68Ga)-Prostate Membrane Specific Antigen Positron Emission Tomography/Computed Tomography (68Ga-PSMA PET/CT) is an emerging diagnostic modality which is gaining importance in individualized prostate cancer (PCa) management era. This study aimed to investigate the diagnostic accuracy of Ga-68-PSMA PET/CT on primary LN staging before radical prostatectomy (RP) in intermediate and high risk PCa.